Company Overview of Polyphor Ltd
Polyphor Ltd. engages in the discovery and development of macro-cycle drugs. The company offers MacroFinder molecules, which penetrate into the cells to hit intracellular protein-protein interactions (PPI); and PEMfinder molecules that are used to address extracellular large surface PPI-targets. Its macro-cycles drugs target various therapeutic areas, such as hematopoietic stem cell transplantations, leukemia, pseudomonas infections, cystic fibrosis, alpha-1 antitrypsin deficiency, and chronic obstructive pulmonary diseases. The company was founded in 1996 and is headquartered in Allschwil, Switzerland.
Founded in 1996
41 61 567 16 00
41 61 567 16 01
Key Executives for Polyphor Ltd
Polyphor Ltd Key Developments
Similar Private Companies By Industry
|ACIC Europe Limited||Europe|
|Novartis International AG||Europe|
|Speciality European Pharma International AG||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Polyphor Ltd, please visit www.polyphor.com. Company data is provided by Capital IQ. Please use this form to report any data issues.